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Our aim was to determine if less expensive interictal indices can predict which epilepsy patients may benefit from the more
expensive comprehensive pre-surgical evaluation. Surgical treatment was determined based on the results of a comprehensive in-
patient continuous video-EEG monitoring. This evaluation included three interictal tests, which were reviewed retrospectively—
2 hour-sleep-deprived electroencephalogram (SDEEG), magnetic resonance imaging (MRI), and positron emission tomogra-
phy (PET). Sixty-nine patients were evaluated with 35 patients having focal resection (33 temporal, two frontal). When two
or more interictal tests were positive, 77% (27/35) went to surgery, but when one test was positive 23% (8/34) had surgery.
When all tests were negative, only a single patient (1/13 or 7.7%) had surgery, a frontal resection. The positive predictive value
for any single interictal test was 68%, while it was higher for any combination of two positive tests (77–83%). PET was the
most sensitive (0.86) single interictal test, compared to SDEEG (0.66) and MRI (0.66). The odds ratio for predicting surgical
treatment for a positive PET, SDEEG, or MRI was 8.57, 4.01, and 4.01, respectively. MRI was three and PET was six times
the cost of a SDEEG. The combination of SDEEG and MRI had the best cost/PPV ratio. Seventy-nine percent (11/14) of the
patients with three positive tests were seizure free following focal resection compared to 43% (9/21) when less than three tests
were positive (P ≤ 0.05). Interictal tests may predict which patients are most likely to benefit from comprehensive pre-surgical
evaluation. Two or more positive tests are the most predictive. If all tests are negative, it is unlikely that the patient would qualify
for surgical treatment. The combination of SDEEG and MRI may be more cost-effective as outpatient screening tools.
c© 2002 Published by Elsevier Science Ltd on behalf of BEA Trading Ltd.
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INTRODUCTION
Although of substantial diagnostic benefit in the
selection of patients with medically intractable
epilepsy for focal resection, pre-surgical evaluation
that includes analysis of 24 hour-video-EEG telemetry
(ictal and interictal EEG), multi-modality imaging,
neuropsychological evaluation and WADA testing is
very expensive. Several investigators have addre-
ssed the need for a cost/benefit analysis of the
comprehensive evaluation1–3. To date, there have
been two evaluations of the cost-effectiveness of
anterior temporal lobectomy in the US4, 5. These
were based on complex models with many variables
but appeared to demonstrate marginally favorable
results when compared to other operative procedures.
However, all patients who underwent pre-surgical
evaluation were included in the costs incurred for
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ATL. While it is difficult to determine the percent
of non-surgical candidates in one series, 33% of
the patients were deemed unsuitable candidates after
the inpatient evaluation for ATL4. This represents
a substantial increase in the overall cost of ATL.
Improving the selection process for patients who are
to be considered for inpatient pre-surgical evaluation
may aid in reducing the overall cost of ATL and
thereby increase the cost/benefit ratio.
To determine if a patient might benefit from the pre-
surgical evaluation, epilepsy centers typically assess
patient history, seizure semiology, physical exam, and
the routine EEG. However, even with this assessment,
many patients undergo an expensive comprehensive
pre-surgical evaluation who are ultimately ineligible
for surgical resection. We sought to determine if less
expensive interictal tests could reliably predict the
outcome of the comprehensive pre-surgical evaluation,
i.e. surgical treatment or surgical ineligibility. To
address this question, we chose to evaluate three
interictal tests that are routinely utilized during our
inpatient evaluation, the 2 hour-SDEEG, MRI, and
PET and compare them to cost. These tests can
be done on an outpatient basis to assess surgical
eligibility.
PATIENTS AND METHODS
Ninety-nine consecutive patients were admitted for
pre-surgical evaluation between October 1993 and
April 1996 at Baptist Hospital, Wake Forest Uni-
versity. Pre-surgical evaluation included 24 hour-
video-EEG monitoring with electrographic analysis
of interictal data (2 hour-SDEEG tracing obtained
during sleep), ictal data, seizure semiology, ictal
SPECT, PET, MRI, and neuropsychological assess-
ment. The interictal tests (SDEEG, MRI and PET)
were determined to be positive or negative at the
time of the pre-surgical evaluation and used in the
determination of surgical candidacy. These test results
were retrospectively compiled.
Thirty patients were excluded from the study that
had large structural lesions (tumors, infarcts, cysts, en-
cephalomalacia) (17), prior intracranial surgery (two),
progressive neurological disease (one), or did not have
all three interictal tests (10). Sixty-nine patients were
evaluated. Based on the results of the comprehensive
evaluation, patients were recommended for focal
resective surgery (23), further evaluation with invasive
electrode recordings (14), or non-surgical medical
treatment (32). Following the evaluation with invasive
recordings, patients were recommended for focal
surgery (12) or determined to be ineligible for surgical
resection (two). Of the 69 patients included in the
study, 37 were female while 32 were male. Ages
ranged from 11 to 66 years, mean 35 years. Seizure
onset ranged from Birth to 38 years, with a mean onset
of 10 years and mean duration 25 years.
EEG. There is no definitive method of data col-
lection between institutions in the determination of
lateralization/localization of the interictal EEG during
the pre-surgical evaluation. Various methods for
evaluation of interictal spikes include evaluation of the
baseline EEG at the onset of the inpatient monitoring
prior to medication taper, continuous assessment of
time samples during the entire monitoring period,
sleep-deprived recordings, and combinations of early
baseline and time samples obtained throughout the
monitoring period6–10. Additionally, one series uti-
lized six outpatient EEGs, comprising three pairs of
awake and asleep recordings in their determination11.
As part of our pre-surgical protocol we routinely
assess a 2 hour-SDEEG based on previously published
criteria9. Spikes and sharp waves were manually
counted during each inpatient evaluation. This was
determined pre-operatively relatively early in the
evaluation and thus was not biased by surgical
candidacy. SDEEGs were considered positive if there
was ≥90% lateralization of epileptiform discharges.
The interictal spikes were additionally classified by
location (temporal, frontal, fronto-temporal, parietal,
occipital). To be considered positive there had to
be six or more epileptiform discharges or less than
six but with concordant focal background slowing.
SDEEGs were considered negative if there was <90%
lateralization of epileptiform discharges, less than
six discharges without slowing, and multifocal or
generalized SDEEGs. Ictal data was not used in the
determination of the positivity or negativity of the
SDEEG. Post-ictal spikes were not counted until the
background had returned to normal for each patient.
The SDEEG was performed on average during the
fourth day of admission without significant difference
between the surgical and non-surgical groups, 3.71
and 3.68, respectively. On the average, each patient
had 2.2 seizures prior to the SDEEG being recorded
with the proportion slightly higher in the non-surgical
group compared to the surgical group, 2.8 and
1.7, respectively. The mean number of seizures that
occurred during the SDEEG was 0.5, however, this
result was skewed by one patient who had 27 brief
4–12 seconds non-localizing electrographic seizures
during the tracing. This patient was also in the non-
surgical group and had a negative SDEEG with no lo-
calized spikes and sharp waves. Excluding this patient
the mean was 0.1 seizures/tracing. Additionally, one
of these patients had intractable frontal lobe epilepsy,
with typically two to 10 seizures per day prior to
the recording. There was no significant difference in
the number of seizures during the SDEEG for the
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surgical group compared to the non-surgical group,
11% (4/35) and 15% (5/34), respectively (P = 0.72).
MRI. High-resolution MRI images of the tempo-
ral lobes were obtained using a fast spin echo
T2-weighted sequence (TR 4000/TE eff 102) and a
T1-weighted 3D-FT, spoiled gradient echo sequence
(TR 45/TE 5 and a 35 degree flip angle). In addition to
subjective interpretation for lesions or abnormalities,
47/64 (75.8%) had hippocampal volumes calculated
following thresholding and segmentation of the hip-
pocampus bilaterally by computer analysis of 3 mm
contiguous coronal T2-weighted images. There was no
significant difference in the percent of patients with
volumetric analysis in the surgical group compared
to the non-surgical group, 77% (27/35) and 71%
(24/34), respectively (P = 0.81). Additionally, a
blind reading was performed on 28 of the images
in which volumetric data was obtained. MRIs with
discrete lesions, or with focal unilateral hippocampal
atrophy or abnormal signal changes were considered
positive. Patients with large lesions were excluded.
PET. An interictal PET using 10 mCi[18F] FDG was
obtained on the first or second day of admission prior
to medication taper and ictal recordings. An EEG was
performed during the uptake phase of the FDG to
ensure that the study was obtained during the interictal
period. The PET was considered positive if there was
a focal area of glucose hypometabolism.
The interictal tests were analyzed within categories;
three interictal tests, two interictal tests, and single
interictal tests. Within the category of two interictal
tests, the SDEEG and MRI, the MRI and PET, and
the SDEEG and PET were separately assessed. Ad-
ditionally, the data was analyzed separately according
to the number of positive tests within each category.
None of the patients with three positive tests had
discordant results. Only four patients with two positive
tests had discordant results. For data analysis, this
pair of discordant tests would be considered under the
category of one positive test as ultimately only one
side would be surgically remedial.
A 2 × 2 analysis was performed for each test
and combinations of tests. Sensitivity, specificity,
positive predictive value (PPV), negative predictive
value (NPV) and the odds ratio were calculated.
The odds ratio was calculated by: [P(A)/P(not
A)]/[P(B)/P(not B)] with the numerator denoting
odds of undergoing surgery and the denominator
representing the odds of not having surgery. Statistical
significance was set at ≤0.05. The accuracy of a test
was determined by calculating the percent of patients
with true test positive results and true test negative
results/total number of patients.
The direct cost for each test was determined by
contact with the appropriate billing personnel for
each department and included hospital and physician
charges. Indirect costs were not included. Cost was
also calculated for each combination of tests. The cost
for each test and test combinations was compared
to the least expensive test, the 2 hour-sleep-deprived
EEG, and a relative cost for each was determined. A
cost/benefit ratio was determined in which benefit was
equated to the positive or negative predictive value.
RESULTS
Of the 69 patients evaluated, 35 had a focal resection
(33 temporal, two frontal). Of the 33 temporal
lobectomies, 17 were right and 16 were left. Thirty-
four patients did not fulfill the criteria for surgical
eligibility. Two patients who had three positive tests
were ineligible for surgery due to the demonstration
of a contralateral temporal ictal onset compared to
the three interictal tests and bilateral independent
posterior quadrant ictal onsets, respectively, with
surface recorded EEG. Additionally, two patients who
had two positive tests were ineligible for surgery due
to bilateral independent temporal ictal onsets with one
confirmed by invasive electrode recordings.
Follow-up ranged from 1 year and 10 months to
4 years (mean = 3 years). 57.1% (20/35) of the
patients were seizure-free following focal resection
(Engel Class I), while 80% (28/35) were seizure-free
or had improved control (Engel class I/II)12.
Prediction of surgical and non-surgical treatment
In the category of three interictal tests, when all
three tests were positive, 82.4% (14/17) of the
patients underwent focal resection, compared to
40.4% (21/52) when less then three tests were positive
(P ≤ 0.01). When any two or all three tests were
positive, 77.1% (27/35) had surgery, but when zero or
one test was positive, 23.5% (8/34) had surgery (P ≤
0.001). However, when all three tests were negative,
only 7.7% (1/13) had surgery (frontal resection) (P ≤
0.001). When all three tests were positive, 17.6%
(3/17) were ineligible for surgery, while when two or
three tests were positive 22.9% (8/35) were ineligible.
In the category of two interictal tests, each
combination of two positive tests were predictive
of focal surgical resection: PET and MRI, SDEEG
and MRI, SDEEG and PET, 83.3% (20/24), 78.9%
(15/19), 76.9% (20/26), respectively (P ≤ 0.01).
Although the combination of a positive PET and
MRI predicted a slightly higher rate of focal surgical
resection compared to the other combinations, it was
not statistically significant. Considering combinations
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Table 1: Prediction of surgical eligibility based on interictal tests.
Categories: Sensitivity Specificity PPV NPV Odds ratio
Three interictal tests:
Three positive tests 0.40 0.91 0.82 0.60 6.89
Any two or more positive tests 0.77 0.76 0.77 0.76 10.97
Any one or more positive tests 0.97 0.35 0.61 0.92 18.55
Two interictal tests:
When two tests are positive:
SDEEG & MRI 0.43 0.88 0.79 0.60 5.63
MRI & PET 0.57 0.88 0.83 0.67 6.22
SDEEG & PET 0.57 0.82 0.77 0.65 10.00
When one or more tests are positive:
SDEEG & MRI 0.89 0.47 0.63 0.80 6.89
MRI & PET 0.91 0.43 0.61 0.83 7.75
SDEEG & PET 0.94 0.47 0.65 0.89 14.67
Single interictal tests:
SDEEG 0.66 0.68 0.68 0.66 4.01
MRI 0.66 0.68 0.68 0.66 4.01
PET 0.86 0.59 0.68 0.80 8.57
PPV, positive predictive value; NPV, negative predictive value; MRI, magnetic resonance imaging; SDEEG, sleep-deprived
electroencephalogram; PET, positron emission tomography. P ≤ 0.01 for each test combination or single test.
of two negative interictal tests, the SDEEG and PET
predicted the highest rate of surgical ineligibility 88.9
(16/18), compared to MRI and PET or SDEEG and
MRI: 83% (15/18), 80% (16/20), respectively, but
was not statistically significant.
With single interictal tests, 68% of the patients
with any single positive test had surgery (P ≤ 0.01).
However, only 20% (5/25) of the patients with
a negative PET had surgery, while 34.2% (12/35)
underwent surgery when either the SDEEG or the MRI
was negative, but this was not statistically significant.
Predictive utility of interictal tests
Table 1 demonstrates the sensitivity, specificity, PPV,
NPV and odds ratio within each category of interictal
tests. The best positive predictor across the categories
of three interictal tests or two interictal tests was
when all tests within that category were positive.
Within these categories, there was greater sensitivity
when one or more tests were positive as compared to
requiring all tests to be positive. However when fewer
tests were positive, the specificity was reduced.
For the category of three interictal tests, when all
three were positive, the tests were very specific but
not sensitive in detecting all surgical cases. The best
combination of sensitivity and specificity occurred
within the group of any two or more positive tests. The
odds for predicting if a patient would undergo surgery
when one or more tests were positive was 18.6 times
greater than when all the tests were negative.
When comparing two interictal tests, the combi-
nation of a positive SDEEG and MRI was specific,
but not very sensitive. Combining the PET with
either the SDEEG or MRI increased the sensitivity
compared to the combination of SDEEG and MRI.
The combination of PET and SDEEG had the best
odds ratio for any two positive tests.
Among single interictal tests, the PET was the most
sensitive, but slightly less specific than the SDEEG or
MRI. Additionally, the PET had the highest odds ratio
for predicting surgical treatment (8.57). It was also
the most accurate test having the highest proportion of
true positive and true negative tests (72.5%), compared
to MRI (66.7%) and SDEEG (66.7%).
Cost
The category of three interictal tests was the most
expensive method and had the highest cost/PPV
[Fig. 1]. In the category of two interictal tests,
the combination of SDEEG and MRI was the least
expensive, and had the best cost/PPV ratio. Among
single interictal tests, the SDEEG was the least
expensive and had the best cost/PPV ratio.
Post-surgical seizure freedom and interictal tests
When comparing all three interictal tests in predicting
seizure freedom following focal resection, only
when all three interictal tests were positive was
there a statistically significant proportion of patients
seizure-free compared to when less than three tests
were positive, 78.6% (11/14) and 42.9% (9/21),
respectively (P ≤ 0.05). Although each of the
following combinations of three interictal tests were
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Fig. 1: Cost/predictive comparison. The 12 data points represent each testing condition listed under the categories in Table 1,
plotting positive predictive value vs. cost. A single positive interictal test is represented by •; two interictal tests (one or two
positive tests) are represented by ; two positive interictal tests are represented by . The number of positive interictal tests for
all three tests is represented by N. SDEEG, sleep-deprived electroencephalogram; MRI, magnetic resonance imaging; PET,
positron emission tomography.
not significant, proportionately less patients were
seizure-free when successively fewer interictal tests
were positive. When three tests were positive, 92.9%
(13/14) had improved control (Engel I/II), compared
to 71.4% (15/21) when less than three tests were
positive. When only two of three interictal tests were
positive, 50% (7/14) were seizure-free, while 28.6%
(2/7) were seizure free when less than two of three
tests were positive. When two of three tests were
positive 78.6% (11/14) had improved seizure control
(Engel I/II) compared to 57.1% (4/7) when less than
two of three tests were positive. When only one of
three tests were positive, 33% (2/6) were seizure-
free, and 66.7% (4/6) were improved (Engel I/II)
compared to no improvement when all three interictal
tests were negative (1/1).
Regarding combinations of two interictal tests in
predicting seizure freedom, only the combination
of both a positive MRI and a positive PET was
statistically significant with 71.4% (15/21) of the
patients becoming seizure free compared to 35.7%
(5/14) seizure free when less than both tests were
positive (P ≤ 0.05). The combination of a positive
SDEEG and MRI, or a positive SDEEG and PET
trended towards significance in predicting seizure
freedom (P ≤ 0.1). When only one interictal test
of a particular combination of two tests was positive,
the predicted seizure-free rate declined by 11% on the
average.
There was no significant difference between positive
single interictal tests in predicting seizure freedom
for the SDEEG 65.2% (15/23), MRI 65.2% (15/23),
or PET 63.3% (19/30) compared to when each of
these tests were negative, SDEEG 41.7% (5/12), MRI
41.7% (5/12), or PET 20% (1/5), respectively.
DISCUSSION
We examined three interictal tests, the 2 hour-sleep-
deprived EEG, MRI, and PET based on the outcome
of focal surgical resection vs. surgical ineligibility
of patients admitted for pre-surgical evaluation.
Although these three interictal tests form part of
the expensive comprehensive inpatient evaluation, our
results show that these less expensive interictal tests
can predict eligibility for surgical treatment, and,
perhaps more importantly, surgical ineligibility. Many
series have demonstrated the predictive capabilities
of interictal tests in temporal lobe epilepsy6–11, 13–17.
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However, none have reported the best combination of
three interictal tests in predicting surgical eligibility,
especially in relation to cost.
In our series, any single positive test could predict
surgical eligibility in approximately 68% (PPV) of the
patients. The PET was the best negative predictor of
surgical eligibility (NPV 80%). It also had the best
odds ratio for predicting surgery (8.6). However, it was
also the single most expensive test. Comparatively, the
SDEEG was the least expensive single test and thus
had the best cost/benefit ratio.
When comparing two interictal tests, the most
information was obtained when both tests were
positive or both were negative. Additionally, any
combination of two positive tests (range 77%–83%)
was more predictive of surgery than any single
test (68%). The least expensive combination, and
slightly better predictor for surgical treatment, was
the SDEEG and MRI. Regarding each of the two test
combinations, it was also slightly more predictive of
post-operative seizure freedom (73%), but was not
significant. When attempting to minimize cost, this
combination would appear to be the most effective.
Many clinicians obtain an outpatient MRI before
considering a patient for pre-surgical evaluation. To
maintain cost-effectiveness, the relatively inexpensive
SDEEG could be added to the clinician’s arsenal of
outpatient tools to increase the predictive value.
The most specific combination and very strong
predictor of surgical treatment was when all tests
were positive in the category of three interictal tests.
However, it was also the most expensive combination,
9.3 times the cost of the SDEEG alone. However,
when all three interictal tests were positive, this was
a strong predictor of seizure freedom (79%) compared
to any combination of fewer than three positive tests
(42.9%). Additionally, there was a graded decline in
those achieving seizure freedom with each drop in
the number of positive tests from three positive, two
positive, one positive, zero positive to 79, 50, 33,
and 0%, respectively. Only one subject (3%), that
we would have predicted to be ineligible for focal
resection having negative results in all three tests, had
a frontal lobe resection (NPV 92%), but this was a
palliative procedure. None of the patients undergoing
temporal lobe resection had negative results in all
three interictal tests. Hence, the performance of all
three tests, which may be used in the outpatient
setting, may allow exclusion of patients who are not
appropriate surgical candidates, thus saving the cost
of an expensive comprehensive inpatient evaluation.
Under these conditions, the patient would also have
a higher likelihood of a good surgical outcome
following focal resection (86%). This would also give
a more accurate characterization of the likelihood of a
good surgical outcome prior to surgery.
Due to increasing economic constraints in health
care, it could be argued that when two or three
of the interictal tests are positive and concordant,
the inpatient comprehensive evaluation could be
eliminated. We would argue against such an approach.
When we analyzed all three interictal tests, 22.9%
(8/35) of the patients that we would have predicted
to be good surgical candidates based on two or
three positive interictal tests were ineligible for focal
resection. Conversely, 23.5% (8/34) of the patients
that we would have predicted to be ineligible, zero
or one positive tests, were ultimately determined to
have surgically treatable epilepsy upon completion
of the comprehensive evaluation. Nevertheless, two
or three positive and concordant interictal tests were
highly predictive of surgical treatment. Consequently,
the performance of these tests in the outpatient setting
could yield valuable diagnostic information. If two or
more tests were positive and concordant, the patient
would have a high probability for surgical eligibility
following completion of the comprehensive inpatient
evaluation.
There are several limitations when trying to
extrapolate our data to the outpatient setting. The MRI
and PET can easily be performed in the outpatient
setting. However, the sleep-deprived EEG may be
more problematic. There is an inherent problem of
trying to keep an outpatient awake for 24 hours.
During the inpatient monitoring this is accomplished
by the constant vigilance of the technical staff, but in
the outpatient setting, patients tend not to stay awake
all night and may be only partially sleep deprived
(personal observation). This raises the question of
whether partial sleep deprivation is equivalent to a
fully sleep-deprived recording. In one surgical series,
six outpatient non-sleep-deprived EEGs totaling 4.5
hours of recording was predictive of seizure freedom
at 5-year follow up11. Thus is the distinction between
partial sleep deprivation and full sleep deprivation
that important? Further studies may be necessary to
evaluate this. Another question concerns how a few
seizures in the days immediately prior to the SDEEG
impact the data. There was no significant difference
in our series between the surgical and non-surgical
group in the number of seizures prior to recording
the SDEEG. Additionally, since the SDEEG was done
typically on day 4 of admission, a slow anticonvulsant
taper was underway. However, does this taper have any
impact on the diagnostic yield of the SDEEG? Later in
the monitoring period when anticonvulsants have been
withdrawn and the patient has had several seizures,
spike frequency may increase in secondary foci, but
the site of maximum abnormality can remain relatively
stable6. However, this effect would tend to lower the
spike ratio below 90%, making it a negative test in our
series. This would thus lower the predictive value and
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increase the cost/PPV ratio. Therefore, our tests could
potentially have a higher predictive value if performed
on outpatients on their maintenance anticonvulsants.
As a first approximation of cost-effectiveness, recent
studies have demonstrated marginal cost-effectiveness
of ATL with the results highly dependent on surgical
outcome and quality of life4, 5. Since many patients
need to undergo the comprehensive evaluation in
order to determine the best surgical candidates, the
use of these three interictal tests in the outpatient
setting, may help reduce the overall lifetime costs
incurred per patient by improving the selection of
appropriate surgical candidates. In one surgical series
patients with 100% localized spikes on six outpatient
awake and asleep EEG recordings underwent ATL
without inpatient evaluation providing that there were
no other discordant results11. In their group of 28
non-monitored patients 61% were seizure free while
93% had a ≥75% reduction in seizure frequency at 5-
year follow up. These proportions were similar to their
inpatient monitored group with unilateral epileptiform
discharges and better than their monitored group with
other interictal patterns. At the time of their moni-
toring, 1 week of inpatient monitoring was six times
the cost of the outpatient EEGs and thus represented
a significant cost saving. Unofficial estimates of the
overall cost of the pre-surgical evaluation, without
invasive monitoring, range from three to 10 times
the cost of all three interictal tests at our institution.
This could represent a substantial cost saving in those
ineligible patients. However, a complete cost-effective
study remains to be performed. Although the cost
for each test may vary per institution and region,
the order of increasing cost is relatively uniform;
EEG<MRI<PET. Since costs are relatively specific
per institution, similar relative cost ratios could be
determined for each center to better assess their
relative cost-effectiveness.
Occasionally, the cost of the comprehensive pre-
surgical evaluation is more concerning to the patient
than the surgery, especially if the outcome of the
evaluation should result in surgical ineligibility. By
performing these tests prior to the inpatient evaluation,
the clinician would have a more definitive and cost-
effective assessment of their surgical eligibility. If the
interictal tests were all negative, the clinician may
consider other treatment options prior to considering
the expensive inpatient pre-surgical evaluation.
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